Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: Putative inhibitors of HIV-1 integrase

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2510-2516

  Vandegraaff, N ^a   Kumar, R ^a   Hocking, H ^a   Burke T R , Jr ^a   Mills, J ^a   Rhodes, D ^a   Burrell, C J ^a   Li, P ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5,8 DIHYDROXYNAPHTHOQUINONE; COMPLEMENTARY DNA; EXTRACHROMOSOMAL DNA; INTEGRASE INHIBITOR; L 17; L 708 906; L 731 988; LAMIVUDINE; QUERCETIN; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE; ZINTEVIR;

ANTIVIRAL ACTIVITY; ARTICLE; BIOASSAY; CELL CULTURE; CELL FREE SYSTEM; CONTROLLED STUDY; DNA INTEGRATION; DNA SYNTHESIS; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

ACETOACETATES; CELLS, CULTURED; DNA, VIRAL; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; HYDRAZINES; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDES; VIRUS REPLICATION;

EID: 0034871310     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2510-2516.2001     Document Type: Article

References (51)

1. Retroviral integration: Structure of the initial covalent product and its precursor, and a role for the viral IN protein
2. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
3. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection
4. Hydroxylated aromatic inhibitors of HIV-1 integrase
5. The barrier-to-autointegration protein is a host factor for HIV type 1 integration
6. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1
7. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
8. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone
9. (-)-2′-deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro
10. A role for DNA-PK in retroviral DNA integration
11. Human immunodeficiency virus integration in a cell-free system
12. HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer
13. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1
14. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase
15. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)
16. HIV-1 cDNA integration: Requirement of HMG I(Y) protein for function of preintegration complexes in vitro
17. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules
18. Inhibitors of human immunodeficiency virus integrase
19. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds
20. - cell surviving infection with the acquired immune deficiency syndrome retrovirus
21. Retroviral DNA integration: Structure of an integration intermediate
22. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
23. Retroviral cDNA integration: Mechanism, applications and inhibition
24. Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites
25. Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds
26. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
27. Selective extraction of polyoma DNA from infected mouse cell cultures
28. Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro
29. Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: Application to inhibitor isolation
30. Characterization of HIV replication complexes early after cell-to-cell infection
31. Structure-activity relationships: Analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type I integrase and replication
32. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells
33. Retroviral cDNA integration: Stimulation by HMG I family proteins
34. Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model
35. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus
36. Chicoric acid analogues as HIV-1 integrase inhibitors
37. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures
38. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition
39. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1
40. The retrovirus pol gene encodes a product required for DNA integration: Identification of a retrovirus int locus
41. Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro
42. Inhibitors of human immunodeficiency virus integrase
43. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: A comparative molecular field analysis (CoMFA) study
44. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture
45. Inhibitors of HIV-1 replication that inhibit HIV integrase
46. Integration is essential for efficient gene expression of human immunodeficiency virus type 1
47. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes
48. HIV-1 replication is controlled at the level of T cell activation and proviral integration
49. Inhibition of productive human immunodeficiency virus-1 infection by cobalamins
50. Cobalamin inhibition of HIV-1 integrase and integration of HIV-1 DNA into cellular DNA
51. Hydrazide-containing inhibitors of HIV-1 integrase